# The National Health Service (Pharmaceutical Services) (Scotland) Regulations 2009, Paragraph 3: Determination of applications

Extent: S

(1) In considering an application to which regulation 5(10)(a) applies, the Board shall have regard to—
(a) the pharmaceutical services already provided in the neighbourhood of the premises named in the application by persons whose names are included in a pharmaceutical list;
(b) pharmaceutical services to be provided in the neighbourhood at these premises by any person whose name is included in the provisional pharmaceutical list;
(c) any representations received by the Board under paragraph 1;
(d) any information available to the Board which, in its opinion, is relevant to consideration of the application;
(e) the consultation analysis report submitted in accordance with regulation 5A;
(f) the pharmaceutical care services plan; and
(g) the likely long term sustainability of the pharmaceutical services to be provided by the applicant.
(2) The Board may, if it considers that oral representations are unnecessary, determine the application without hearing oral representations.
(3) In any case in which the Board decides to hear oral representations, the Board must—
(a) give the applicant and any person from whom it received representations under paragraph 1 reasonable notice of the meeting at which such representations are to be heard;
(b) permit the applicant and any person making representations at the hearing to be assisted by another person;
(c) permit the applicant or any person making representations at the hearing either to—
(i) speak to their own representations; or
(ii) nominate the person assisting them to speak on their behalf; and
(d) confirm that any person assisting the applicant or any person making representations at the hearing is not appearing in the capacity of counsel, solicitor or paid advocate.
(4) The Board shall, subject to sub-paragraph (5), make a determination on the application within 6 weeks of the date that they received the consultation analysis report under regulation 5A.
(5) A 6 week determination period under sub-paragraph (4) may be extended in exceptional circumstances and in such an event the Board must inform the applicant and any person or body notified under paragraph 1 or 2A, of the extended time period and the reasons for it.
(6) The Board’s determination of an application must include—
(a) a summary of the consultation analysis report submitted in accordance with regulation 5A;
(b) an explanation of how the consultation analysis report was taken into account in arriving at the decision, with regard to the tests under regulation 5(10), as applicable; and
(c) the reasons for its decision.
(7) The functions of the Board under this paragraph shall be exercised on its behalf by the Pharmacy Practices Committee in accordance with Part I of Schedule 4.

---
Source: https://www.legislation.gov.uk/ssi/2009/183/schedule/3/paragraph/3 (the official version)
Page: https://openlegislation.uk/national-health-service-pharmaceutical-services-scotland-regulations-2009/schedule-3/paragraph-3
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.